Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The Food and Drug Administration approved the first generic version of Jazz Pharmaceutical's drug Xyrem to treat patients with narcolepsy.
Andrew Left, a well-known short seller at Citron Research, predicts generic drug firm Lannett will be the first drugmaker to go bankrupt amid ongoing drug pricing scrutiny, according to a report released Tuesday.
When asked how the drug industry should react to President-elect Donald Trump's vow to "bring down drug prices," Pfizer CEO Ian Read had an unlikely response: Raise drug prices.
Cambridge, Mass.-based Biogen entered a licensing agreement with Forward Pharma for the Danish drugmaker's multiple sclerosis treatments.
Hospitals in the Washington, D.C. area have voiced an urgent call to increase collections of blood supplies as they prepare for potential emergencies during the upcoming presidential inauguration weekend, reports WTOP.
In a recent press release, HPS, a group purchasing organization (GPO) with more than 3,600 members, including 144 acute care and 1,466 non-acute care facilities, in 20 states, signed an agreement with Resource Optimization & Innovation (ROi), a provider-owned supply chain…
Staff
The U.S. Supreme Court on Friday agreed to review a dispute between Basel, Switzerland-based Novartis and Thousand Oaks, Calif.-based Amgen on whether drug companies must wait six months after winning regulatory approval before selling "copycat" versions of biologic drugs, reports…
HPS, a group purchasing organization based in Middleville, Mich., entered a strategic supply chain partnership with Resource Optimization & Innovation, a provider-owned supply chain services company in St. Louis.
Vermont Sen. Bernie Sanders (I) on Thursday criticized 13 Senate Democrats for voting against a measure he proposed to control drug costs, saying they lacked the "guts" to stand up to the drug industry, reports USA Today.
Fujifilm Medical Systems plans to remove four legacy duodenoscope models from clinical use "based on the limited number currently in use," according to a Food and Drug Administration safety alert issued Jan. 13.